INT354093

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.01
First Reported 2010
Last Reported 2010
Negated 0
Speculated 0
Reported most in Body
Documents 1
Total Number 1
Disease Relevance 1.04
Pain Relevance 0.18

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

molecular_function (Ccdc135) biological_process (Ccdc135) cytoplasm (Ccdc135)
Anatomy Link Frequency
visceral 1
Ccdc135 (Mus musculus)
Pain Link Frequency Relevance Heat
cytokine 11 93.72 High High
Inflammatory response 3 86.20 High High
Potency 1 75.52 Quite High
alcohol 1 51.76 Quite High
antagonist 4 5.00 Very Low Very Low Very Low
depression 3 5.00 Very Low Very Low Very Low
Cannabinoid 3 5.00 Very Low Very Low Very Low
palliative 1 5.00 Very Low Very Low Very Low
Central nervous system 1 5.00 Very Low Very Low Very Low
Inflammation 1 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Appetite Loss 90 100.00 Very High Very High Very High
Body Weight 1 99.36 Very High Very High Very High
Cancer 36 99.32 Very High Very High Very High
Toxicity 5 96.44 Very High Very High Very High
INFLAMMATION 4 85.84 High High
Congenital Anomalies 11 83.68 Quite High
Acute Disease 1 54.00 Quite High
Lung Cancer 1 53.84 Quite High
Disease 2 46.48 Quite Low
Nicotine Addiction 1 45.28 Quite Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
We completed a pilot trial of 36 subjects to evaluate the safety and effectiveness of administering 4-g Lovaza® (omega-3-acid ethyl esters) for a 6-week period, to cancer patients (>65% lung), with early stages of CC (unplanned weight loss of 5% of their body weight within the past 3 months) and observed changes in markers of toxicity, visceral and skeletal protein status, nutritional intake, cytokines, functional status and physical activity.
Negative_regulation (loss) of stages in visceral associated with appetite loss, toxicity, body weight, cancer and cytokine
1) Confidence 0.01 Published 2010 Journal Curr Treat Options Oncol Section Body Doc Link PMC3016925 Disease Relevance 1.04 Pain Relevance 0.18

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox